Also Read: DCM Shriram to acquire Hindusthan Specialty Chemicals for ₹375 crore
While the company has indicated no material operational or financial impact, it has quantified a potential financial exposure of ₹40 crore, which is currently under evaluation. DCM Shriram has stated it is considering legal recourse through appropriate forums.
Fourth Quarter ResultsDCM Shriram consolidated net profit rose 51.9% year-on-year to ₹178.9 crore, up from ₹117.8 crore in the same quarter last year. The company saw robust growth across segments, lifting both revenue and margins.
Revenue for the March quarter came in at ₹2,876.7 crore, up 19.9% from ₹2,399.3 crore a year ago. Operating performance was equally solid, with EBITDA growing 52.8% to ₹405.3 crore compared to ₹265.3 crore in the year-ago period. The company’s EBITDA margin improved significantly to 14.1% from 11.1% last year, reflecting better realisations and operational efficiencies.
Also Read: Sugar business will be more profitable than chemicals this year: DCM Shriram
Shares of DCM Shriram Ltd ended at ₹1,350.00, down by ₹6.50, or 0.48%, on the BSE.